Prostate-specific antigen best practice policy-part II: prostate cancer staging and post-treatment follow-up

By Carroll P.   Coley C.   McLeod D.   Schellhammer P.   Sweat G.   Wasson J.   Zietman A.   Thompson I.  

Urology, Vol. 57, Iss. 2, 2001-02 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? part I: framing the debate

By Barry M.J.   Fleming C.   Coley C.M.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 1, 1995-07 ,pp. : 2-13

Elsevier

Access to resources Recommend Favorite

Prostate-specific antigen testing for early diagnosis of prostate cancer: formulation of guidelines

By Carter H.B.   Pearson J.D.  

Urology, Vol. 54, Iss. 5, 1999-11 ,pp. : 780-786

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part II: early detection strategies

By Coley C.M.   Barry M.J.   Fleming C.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 2, 1995-08 ,pp. : 125-141

Elsevier

Access to resources Recommend Favorite

Should medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer? Part IV: Estimating the risks and benefits of an early detection program

By Barry M.J.   Fleming C.   Coley C.M.   Wasson J.H.   Fahs M.C.   Oesterling J.E.  

Urology, Vol. 46, Iss. 4, 1995-10 ,pp. : 445-461

Elsevier

Access to resources Recommend Favorite